PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SR 144528. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

14 hits

Bibliografisk träff 2019-06-14

Altered Swimming Behaviors in Zebrafish Larvae Lacking Cannabinoid Receptor 2.

Acevedo-Canabal A, Colón-Cruz L, Rodriguez-Morales R, Varshney GK, Burgess S, González-Sepúlveda L, Yudowski G, Behra M, Behra M.

Cannabis Cannabinoid Res · research-article; journal article · DOI 10.1089/can.2018.0025

Bibliografisk träff 2013-08-14

The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528).

Kotsikorou E, Navas F, Roche MJ, Gilliam AF, Thomas BF, Seltzman HH, Kumar P, Song ZH, Hurst DP, Lynch DL, Reggio PH.

J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm400070u

Bibliografisk träff 2010-02-03

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.

Abalo R, Cabezos PA, Vera G, Fernández-Pujol R, Martín MI.

Neurogastroenterol Motil · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1365-2982.2009.01466.x

Bibliografisk träff 2010-01-20

Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Raborn ES, Cabral GA.

J Pharmacol Exp Ther · research-article; journal article; research support, n.i.h., extramural · DOI 10.1124/jpet.109.163055

Bibliografisk träff 2009-02-11

AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.

Thewke D, Freeman-Anderson N, Pickle T, Netherland C, Chilton C.

Biochem Biophys Res Commun · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbrc.2009.02.020

Bibliografisk träff 2008-08-29

CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.

Páldy E, Bereczki E, Sántha M, Wenger T, Borsodi A, Zimmer A, Benyhe S.

Neurochem Int · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuint.2008.08.005

Bibliografisk träff 2005-05-01

Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.

Krylatov AV, Maslov LN, Lasukova OV, Pertwee RG.

Bull Exp Biol Med · research support, non-u.s. gov't; journal article · DOI 10.1007/s10517-005-0344-9

Bibliografisk träff 2002-09-01

SR144528 as inverse agonist of CB2 cannabinoid receptor.

Rhee MH, Kim SK.

J Vet Sci · journal article · DOI 10.4142/jvs.2002.3.3.179

Bibliografisk träff 2000-07-01

Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.

Gouldson P, Calandra B, Legoux P, Kernéis A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D.

Eur J Pharmacol · journal article · DOI 10.1016/s0014-2999(00)00439-8

Bibliografisk träff 1999-07-01

Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses.

Bouaboula M, Dussossoy D, Casellas P.

J Biol Chem · journal article · DOI 10.1074/jbc.274.29.20397

Bibliografisk träff 1999-07-01

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.

Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME.

Eur J Pharmacol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(99)00402-1

Bibliografisk träff 1999-02-01

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G, Casellas P.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(24)37993-5

Bibliografisk träff 1999-01-01

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P, Ferrara P.

Life Sci · review; journal article · DOI 10.1016/s0024-3205(99)00285-4

Bibliografisk träff 1998-02-01

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Brelière JC, Le Fur GL.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(24)37266-0